Search Results 101-110 of 37564 for Two-phase
Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous ...
Stage 2 (irreversible lymphedema): Fibrosis — the deposition of loose, disorganized collagen tissue — has occurred. Without intervention, no matter how long the ...
... Phase 2 dose (RP2D) and schedule of KTX-1001 for ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.
Part A: (ADXS11-001 + MEDI4736 Combination Therapy) will determine the safety and tolerability of the combination and to identify a RP2D. Part B: Phase 2 design ...
This study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will evaluate the safety and ...
Phase 1. This two-week phase aims to jump-start your weight loss. You cut out almost all carbs from your diet. · Phase 2. This phase aims to help you lose weight ...
... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti ... The study will be performed in two phases: Phase I will be performed for ...
The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with ...
The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II will ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.